Anti-Emetics Would Be Paid Separately Under Medicare Outpatient Rule
Executive Summary
The chemotherapy-induced nausea treatments Anzemet, Kytril and Zofran would be reimbursed separately rather than bundled with a package of therapeutic services under the 2005 Medicare outpatient prospective payment system proposed rule